Connection

Charles Smith to Proto-Oncogene Proteins c-bcl-2

Back to Details
This is a "connection" page, showing publications Charles Smith has written about Proto-Oncogene Proteins c-bcl-2.
Charles Smith
Connection Strength
0.198
Proto-Oncogene Proteins c-bcl-2
  1. Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. Cancer Biol Ther. 2009 Dec; 8(24):2406-16.
    View in: PubMed
    Score: 0.082
  2. Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell. 2007 Jul; 12(1):66-80.
    View in: PubMed
    Score: 0.070
  3. Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biol Ther. 2011 Aug 01; 12(3):229-38.
    View in: PubMed
    Score: 0.023
  4. Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer. Cancer Biol Ther. 2011 Aug 01; 12(3):239-51.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.